Inflammatory processes

"Inflammatory processes" refers broadly to the complex biological responses initiated by tissue injury or infection involving immune cells, blood vessels, and molecular mediators. The primary function is protective—eliminating pathogens and initiating tissue repair—but dysregulation can lead to chronic disease or excessive tissue damage. Key cellular participants include neutrophils, monocytes/macrophages, lymphocytes, mast cells, basophils, dendritic cells, and platelets[2][4][6]. Molecular mediators include cytokines (such as TNF-alpha and interleukins), chemokines that recruit immune cells via extravasation mechanisms involving selectins and integrins[2], complement proteins that opsonize pathogens for phagocytosis[6], lipid mediators like prostaglandins/leukotrienes[4], among others. Acute inflammation is typically short-lived with rapid cell recruitment aimed at pathogen clearance; chronic inflammation involves persistent immune activation leading potentially to autoimmunity or fibrosis. While many therapeutic agents target components of these pathways—such as cytokine inhibitors—the term "inflammatory processes" does not refer to any single molecule or druggable entity but encompasses an entire networked system essential for host defense yet implicated in numerous pathologies when dysregulated[1][7]. The entry “Inflammatory processes” is not a valid molecular target, receptor name, enzyme name etc.; it describes a broad physiological phenomenon comprising multiple cell types and signaling molecules rather than any one canonical drug target structure. For structured data purposes it should be flagged as incorrect (`is_incorrect: true`) because it lacks specificity required for pharmacological targeting under standard conventions in biomedical databases.[1][2][4]

Other names

InflammationInflammatory responseInflammatory cascade